The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Cross-border purchase within the EU: the actual rules

This is a generated summary. It shows the 5 most-liked posts from a topic of 11, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SC
s.chowdhuryTL3Regular3 Jun 2025#1

Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did.

A coverage question with the paperwork detail included, since that is what determines the answer.

Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which is the useful thing about a well-written denial.

Before I spend a week on it: is my reading of the stated criterion correct, and is there a documented precedent for this specific ground?

43 likes 14mo
IB
i.brobergTL2 Moderator Solution27 Jun 2025#3

Coming back to the opening post, because the follow-up matters more than the original answer.

Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.

8 likes 13mo
ET
e.tammTL2 Moderator14 Jul 2025#5
MSaarinen, post #2: Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent. Go to post

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

31 likes in reply to #2 12mo
EM
e.mikkelsenTL2Member22 Jul 2025#6

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

16 likes 12mo
KP
k.pereiraTL2 Moderator26 Aug 2025 · edited#11
e.mikkelsen, post #6: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

post #10 is right about the mechanism and I think understates the practical bit.

Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and coverage is necessary.

13 likes in reply to #6 11mo

Read the full topic (11 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
CHATJSFEB+37 42 2.1k 1d
Availability by country, dated, with primary sources — one year on
Availability by country, dated, with primary sources — one year on — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this…
AKSCSDCAHK+7 11 850 7mo
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
SCHBFPNVHS+20 25 50k 1d
Availability by country, dated, with primary sources
On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
KOSKJNNSMS+72 81 6.9k 8mo
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
CCJHKSAVN+124 132 9.2k 2mo

Related topics — sharing the tags MHRA, EMA, telehealth

TopicParticipantsRepliesViewsActivity
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person. The…
GIJSATYAS+32 36 13k 1mo
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather than…
SRSRVFZYNV+80 86 5.6k 3h
Discussing something you have already been doing
On the subject in the title: Discussing something you have already been doing Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I…
ECRFOOIAKF+10 14 3.4k 10mo
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…
LCFNJBSCAN+72 78 23k 3mo
Irish differences from the UK position
Posting this under the heading it deserves: Irish differences from the UK position Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category expires.…
KOLNVPNCH+62 66 993 21mo